{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:05:14Z","timestamp":1784354714805,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1038\/nrendo.2009.19","type":"journal-article","created":{"date-parts":[[2009,3,23]],"date-time":"2009-03-23T11:42:26Z","timestamp":1237808546000},"page":"211-218","source":"Crossref","is-referenced-by-count":89,"title":["Novel insights into thyroid hormones from the study of common genetic variation"],"prefix":"10.1038","volume":"5","author":[{"given":"Colin M.","family":"Dayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Panicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrendo200919_CR1","volume-title":"Hot Thyroidology","author":"P Saravanan","year":"2009","unstructured":"Saravanan, P. & Dayan, C. M. Understanding thyroid hormone action and the effects of thyroid hormone replacement\u2014just the beginning not the end. Hot Thyroidology [ http:\/\/www.hotthyroidology.com\/editorial_135.html ] (accessed 5 February 2009)."},{"key":"BFnrendo200919_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2008.04.007","volume":"289","author":"U Schweizer","year":"2008","unstructured":"Schweizer, U., Weitzel, J. M. & Schomburg, L. Think globally: act locally. New insights into the local regulation of thyroid hormone availability challenge long accepted dogmas. Mol. Cell. Endocrinol. 289, 1\u20139 (2008).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFnrendo200919_CR3","first-page":"E715","volume":"258","author":"A Pilo","year":"1990","unstructured":"Pilo, A. et al. Thyroidal and peripheral prodsuction of 3, 5, 3\u2032-triiodothyronine in humans by multicompartmental analysis. Am. J. Physiol. 258, E715\u2013E726 (1990).","journal-title":"Am. J. Physiol."},{"key":"BFnrendo200919_CR4","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1172\/JCI29812","volume":"116","author":"AC Bianco","year":"2006","unstructured":"Bianco, A. C. & Kim, B. W. Deiodinases: implications of the local control of thyroid hormone action. J. Clin. Invest. 116, 2571\u20132579 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo200919_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1210\/edrv.22.4.0435","volume":"22","author":"G Hennemann","year":"2001","unstructured":"Hennemann, G . et al. Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr. Rev. 22, 451\u2013476 (2001).","journal-title":"Endocr. Rev."},{"key":"BFnrendo200919_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1210\/edrv.23.1.0455","volume":"23","author":"AC Bianco","year":"2002","unstructured":"Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J. & Larsen, P. R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23, 38\u201389 (2002).","journal-title":"Endocr. Rev."},{"key":"BFnrendo200919_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tem.2007.11.003","volume":"19","author":"WE Visser","year":"2008","unstructured":"Visser, W. E., Friesema, E. C., Jansen, J. & Visser, T. J. Thyroid hormone transport in and out of cells. Trends Endocrinol. Metab. 19, 50\u201356 (2008).","journal-title":"Trends Endocrinol. Metab."},{"key":"BFnrendo200919_CR8","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1152\/physrev.2001.81.3.1097","volume":"81","author":"PM Yen","year":"2001","unstructured":"Yen, P. M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81, 1097\u20131142 (2001).","journal-title":"Physiol. Rev."},{"key":"BFnrendo200919_CR9","unstructured":"WTCCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661\u2013678 (2007)."},{"key":"BFnrendo200919_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1210\/jc.2003-031641","volume":"89","author":"PS Hansen","year":"2004","unstructured":"Hansen, P. S., Brix, T. H., Sorensen, T. I., Kyvik, K. O. & Hegedus, L. Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins. J. Clin. Endocrinol. Metab. 89, 1181\u20137118 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200919_CR11","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1365-2265.2007.03079.x","volume":"68","author":"V Panicker","year":"2008","unstructured":"Panicker, V. et al. Heritability of serum TSH, free T4 and free T3 concentrations: a study of a large UK twin cohort. Clin. Endocrinol. (Oxf.) 68, 652\u2013659 (2008).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo200919_CR12","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1210\/jcem.87.3.8165","volume":"87","author":"SH Andersen","year":"2002","unstructured":"Andersen, S. H., Pedersen, K. M., Bruun, N. & Laurberg, P. Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J. Clin. Endocrinol. Metab. 87, 1068\u20131072 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200919_CR13","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1210\/jc.2002-021592","volume":"88","author":"RP Peeters","year":"2003","unstructured":"Peeters, R. P. et al. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J. Clin. Endocrinol. Metab. 88, 2880\u20132888 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200919_CR14","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1210\/jc.2006-1331","volume":"92","author":"FJ de Jong","year":"2007","unstructured":"de Jong, F. J. et al. The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. J. Clin. Endocrinol. Metab. 92, 636\u2013640 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200919_CR15","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1210\/jc.2008-0397","volume":"93","author":"V Panicker","year":"2008","unstructured":"Panicker, V. et al. A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. J. Clin. Endocrinol. Metab. 93, 3075\u20133081 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200919_CR16","volume-title":"Clin. Endocrinol. (Oxf.)","author":"WM van der Deure","year":"2008","unstructured":"van der Deure, W. M. et al. The effect of genetic variation in the type 1 deiodinase gene on the inter-individual variation in serum thyroid hormone levels. An investigation in healthy Danish twins. Clin. Endocrinol. (Oxf.), [doi:10.1111\/j.1365\u20132265200803419.x] (2008)."},{"key":"BFnrendo200919_CR17","doi-asserted-by":"publisher","first-page":"E75","DOI":"10.1152\/ajpendo.00571.2004","volume":"289","author":"RP Peeters","year":"2005","unstructured":"Peeters, R. P. et al. A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters. Am. J. Physiol. Endocrinol. Metab. 289, E75\u2013E81 (2005).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrendo200919_CR18","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1089\/thy.2005.15.1223","volume":"15","author":"D Mentuccia","year":"2005","unstructured":"Mentuccia, D. et al. The Thr92Ala deiodinase type 2 (DIO2) variant is not associated with type 2 diabetes or indices of insulin resistance in the old order of Amish. Thyroid 15, 1223\u20131227 (2005).","journal-title":"Thyroid"},{"key":"BFnrendo200919_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/01.HYP.0000256295.72185.fd","volume":"49","author":"O Gumieniak","year":"2007","unstructured":"Gumieniak, O. et al. Ala92 type 2 deiodinase allele increases risk for the development of hypertension. Hypertension 49, 461\u2013466 (2007).","journal-title":"Hypertension"},{"key":"BFnrendo200919_CR20","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.ajhg.2008.04.019","volume":"82","author":"L Arnaud-Lopez","year":"2008","unstructured":"Arnaud-Lopez, L. et al. Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am. J. Hum. Genet. 82, 1270\u20131280 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrendo200919_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.beem.2007.03.006","volume":"21","author":"WM van der Deure","year":"2007","unstructured":"van der Deure, W. M., Peeters, R. P. & Visser, T. J. Genetic variation in thyroid hormone transporters. Best Pract. Res. Clin. Endocrinol. Metab. 21, 339\u2013350 (2007).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"BFnrendo200919_CR22","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1210\/en.2008-0430","volume":"149","author":"WM van der Deure","year":"2008","unstructured":"van der Deure, W. M. et al. Thyroid hormone transport and metabolism by organic anion transporter 1C1 and consequences of genetic variation. Endocrinology 149, 5307\u20135314 (2008).","journal-title":"Endocrinology"},{"key":"BFnrendo200919_CR23","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1210\/en.2008-0169","volume":"149","author":"WM van der Deure","year":"2008","unstructured":"van der Deure, W. M. et al. Organic anion transporter 1B1: an important factor in hepatic thyroid hormone and estrogen transport and metabolism. Endocrinology 149, 4695\u20134701 (2008).","journal-title":"Endocrinology"},{"issue":"Suppl. 835","key":"BFnrendo200919_CR24","first-page":"P78","volume":"16","author":"L Dominguez-Gerpe","year":"2006","unstructured":"Dominguez-Gerpe, L. et al. Study of a possible association between serum levels of T4, T3 or TSH and the SNP S33P of the monocarboxylate transporter 8 (MCT8) Thyroid 16 (Suppl. 835), P78 (2006).","journal-title":"Thyroid"},{"key":"BFnrendo200919_CR25","volume-title":"Clin. Endocrinol. (Oxf.)","author":"R Lago-Leston","year":"2008","unstructured":"Lago-Leston, R. et al. Prevalence and functional analysis of the S107P polymorphism (rs6647476) of the monocarboxylate transporter 8 (SLC16A2) gene in the male population of Northwest Spain (Galicia). Clin. Endocrinol. (Oxf.), [doi:10.1111\/j.1365\u20132265200803377.x] (2008)."},{"key":"BFnrendo200919_CR26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/j.1365-2265.2007.02820.x","volume":"66","author":"PS Hansen","year":"2007","unstructured":"Hansen, P. S. et al. The impact of a TSH receptor gene polymorphism on thyroid-related phenotypes in a healthy Danish twin population. Clin. Endocrinol. (Oxf.) 66, 827\u2013832 (2007).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo200919_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2265.2007.03016.x","volume":"68","author":"WM van der Deure","year":"2008","unstructured":"van der Deure, W. M. et al. Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study. Clin. Endocrinol. (Oxf.) 68, 175\u2013181 (2008).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo200919_CR28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2265.2004.02053.x","volume":"61","author":"E Murphy","year":"2004","unstructured":"Murphy, E. & Williams, G. R. The thyroid and the skeleton. Clin. Endocrinol. (Oxf.) 61, 285\u2013298 (2004).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo200919_CR29","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1093\/hmg\/ddn082","volume":"17","author":"I Meulenbelt","year":"2008","unstructured":"Meulenbelt, I. et al. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum. Mol. Genet. 17, 1867\u20131875 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrendo200919_CR30","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ncb1272","volume":"7","author":"M Dentice","year":"2005","unstructured":"Dentice, M. et al. The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate. Nat. Cell Biol. 7, 698\u2013705 (2005).","journal-title":"Nat. Cell Biol."},{"key":"BFnrendo200919_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0092-8674(03)00771-2","volume":"115","author":"E Abe","year":"2003","unstructured":"Abe, E. et al. TSH is a negative regulator of skeletal remodeling. Cell 115, 151\u2013162 (2003).","journal-title":"Cell"},{"key":"BFnrendo200919_CR32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/jmg.2004.019190","volume":"41","author":"TW Guo","year":"2004","unstructured":"Guo, T. W. et al. Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China. J. Med. Genet. 41, 585\u2013590 (2004).","journal-title":"J. Med. Genet."},{"key":"BFnrendo200919_CR33","first-page":"950","volume":"76","author":"JP Miell","year":"1993","unstructured":"Miell, J. P. et al. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. J. Clin. Endocrinol. Metab. 76, 950\u2013955 (1993).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200919_CR34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1210\/jc.2004-1301","volume":"90","author":"RP Peeters","year":"2005","unstructured":"Peeters, R. P. et al. A polymorphism in type I deiodinase is associated with circulating free insulin-like growth factor I levels and body composition in humans. J. Clin. Endocrinol. Metab. 90, 256\u2013263 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200919_CR35","doi-asserted-by":"publisher","first-page":"880","DOI":"10.2337\/diabetes.51.3.880","volume":"51","author":"D Mentuccia","year":"2002","unstructured":"Mentuccia, D. et al. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor. Diabetes 51, 880\u2013883 (2002).","journal-title":"Diabetes"},{"key":"BFnrendo200919_CR36","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1210\/jc.2004-1977","volume":"90","author":"LH Canani","year":"2005","unstructured":"Canani, L. H. et al. The type 2 deiodinase A\/G. (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 90, 3472\u20133478 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200919_CR37","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1365-2265.2007.02817.x","volume":"66","author":"RP Peeters","year":"2007","unstructured":"Peeters, R. P. et al. The Asp727Glu polymorphism in the TSH receptor is associated with insulin resistance in healthy elderly men. Clin. Endocrinol. (Oxf.) 66, 808\u2013815 (2007).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo200919_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1089\/thy.2006.0298","volume":"17","author":"AL Maia","year":"2007","unstructured":"Maia, A. L. et al. The type 2 deiodinase (DIO2) A\/G polymorphism is not associated with glycemic traits: the Framingham Heart Study. Thyroid 17, 199\u2013202 (2007).","journal-title":"Thyroid"},{"key":"BFnrendo200919_CR39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1210\/jc.2006-1958","volume":"92","author":"N Grarup","year":"2007","unstructured":"Grarup, N. et al. Studies of the common DIO2 Thr92Ala polymorphism and metabolic phenotypes in 7342 Danish white subjects. J. Clin. Endocrinol. Metab. 92, 363\u2013366 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200919_CR40","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1038\/oby.2007.343","volume":"15","author":"M Fiorito","year":"2007","unstructured":"Fiorito, M. et al. Interaction of DIO2 T92A and PPAR\u03b32 P12A polymorphisms in the modulation of metabolic syndrome. Obesity (Silver Spring) 15, 2889\u20132895 (2007).","journal-title":"Obesity (Silver Spring)"},{"key":"BFnrendo200919_CR41","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1126\/science.7291997","volume":"214","author":"JL Leonard","year":"1981","unstructured":"Leonard, J. L., Kaplan, M. M., Visser, T. J., Silva, J. E. & Larsen, P. R. Cerebral cortex responds rapidly to thyroid hormones. Science 214, 571\u2013573 (1981).","journal-title":"Science"},{"key":"BFnrendo200919_CR42","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1172\/JCI110699","volume":"70","author":"JE Silva","year":"1982","unstructured":"Silva, J. E. & Larsen, P. R. Comparison of iodothyronine 5\u2032-deiodinase and other thyroid-hormone-dependent enzyme activities in the cerebral cortex of hypothyroid neonatal rat. Evidence for adaptation to hypothyroidism. J. Clin. Invest. 70, 1110\u20131123 (1982).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo200919_CR43","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1172\/JCI118353","volume":"96","author":"HF Escobar-Morreale","year":"1995","unstructured":"Escobar-Morreale, H. F., Obregon, M. J., Escobar del Rey, F. & Morreale de Escobar, G. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J. Clin. Invest. 96, 2828\u20132838 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo200919_CR44","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1046\/j.1365-2265.2002.01654.x","volume":"57","author":"P Saravanan","year":"2002","unstructured":"Saravanan, P. et al. Psychological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin. Endocrinol. (Oxf.) 57, 577\u2013585 (2002).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo200919_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1034\/j.1600-0447.2002.01250.x","volume":"106","author":"A Engum","year":"2002","unstructured":"Engum, A., Bjoro, T., Mykletun, A. & Dahl, A. A. An association between depression, anxiety and thyroid function\u2014a clinical fact or an artefact? Acta Psychiatr. Scand. 106, 27\u201334 (2002).","journal-title":"Acta Psychiatr. Scand."},{"key":"BFnrendo200919_CR46","doi-asserted-by":"crossref","unstructured":"Panicker, V. et al. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J. Clin. Endocrinol. Metab., doi:10.1210\/jc.2008-1301 (2009).","DOI":"10.1210\/jc.2008-1301"},{"key":"BFnrendo200919_CR47","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/BF03343972","volume":"25","author":"KA Woeber","year":"2002","unstructured":"Woeber, K. A. Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J. Endocrinol. Invest. 25, 106\u2013109 (2002).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo200919_CR48","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/jama.299.7.769","volume":"299","author":"J Jonklaas","year":"2008","unstructured":"Jonklaas, J., Davidson, B., Bhagat, S. & Soldin, S. J. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA 299, 769\u2013777 (2008).","journal-title":"JAMA"},{"key":"BFnrendo200919_CR49","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1210\/jc.2005-0451","volume":"90","author":"BC Appelhof","year":"2005","unstructured":"Appelhof, B. C. et al. Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine\/3, 5, 3\u2032-triiodothyronine therapy. J. Clin. Endocrinol. Metab. 90, 6296\u20136299 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200919_CR50","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1365-2265.2008.03267.x","volume":"69","author":"WM van der Deure","year":"2008","unstructured":"van der Deure, W. M. et al. Polymorphisms in the brain-specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients. Clin. Endocrinol. (Oxf.) 69, 804\u2013111 (2008).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo200919_CR51","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1210\/jc.2006-0448","volume":"91","author":"S Grozinsky-Glasberg","year":"2006","unstructured":"Grozinsky-Glasberg, S., Fraser, A., Nahshoni, E., Weizman, A. & Leibovici, L. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J. Clin. Endocrinol. Metab. 91, 2592\u20132599 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200919_CR52","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1210\/jc.2007-1067","volume":"93","author":"M Torlontano","year":"2008","unstructured":"Torlontano, M. et al. Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients. J. Clin. Endocrinol. Metab. 93, 910\u2013913 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo200919_CR53","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1210\/en.2005-0739","volume":"147","author":"MJ Schneider","year":"2006","unstructured":"Schneider, M. J. et al. Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology 147, 580\u2013589 (2006).","journal-title":"Endocrinology"},{"key":"BFnrendo200919_CR54","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1210\/mend.15.12.0740","volume":"15","author":"MJ Schneider","year":"2001","unstructured":"Schneider, M. J. et al. Targeted disruption of the type 2 selenodeiodinase gene (Dio2) results in a phenotype of pituitary resistance to T4. Mol. Endocrinol. 15, 2137\u20132148 (2001).","journal-title":"Mol. Endocrinol."},{"key":"BFnrendo200919_CR55","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1172\/JCI26240","volume":"116","author":"A Hernandez","year":"2006","unstructured":"Hernandez, A., Martinez, M. E., Fiering, S., Galton, V. A. & St Germain, D. Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J. Clin. Invest. 116, 476\u2013484 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo200919_CR56","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1172\/JCI28253","volume":"117","author":"M Trajkovic","year":"2007","unstructured":"Trajkovic, M. et al. Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J. Clin. Invest. 117, 627\u2013635 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo200919_CR57","doi-asserted-by":"publisher","first-page":"15776","DOI":"10.1073\/pnas.242322099","volume":"99","author":"RC Marians","year":"2002","unstructured":"Marians, R. C. et al. Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc. Natl Acad. Sci. USA 99, 15776\u201315781 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo200919_CR58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1043-2760(98)00026-5","volume":"9","author":"JH Hsu","year":"1998","unstructured":"Hsu, J. H. & Brent, G. A. Thyroid hormone receptor gene knockouts. Trends Endocrinol. Metab. 9, 103\u2013112 (1998).","journal-title":"Trends Endocrinol. Metab."},{"key":"BFnrendo200919_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1086\/431313","volume":"77","author":"CE Schwartz","year":"2005","unstructured":"Schwartz, C. E. et al. Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am. J. Hum. Genet. 77, 41\u201353 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrendo200919_CR60","first-page":"348","volume":"14","author":"S Refetoff","year":"1993","unstructured":"Refetoff, S., Weiss, R. E. & Usala, S.J. The syndromes of resistance to thyroid hormone. Endocr. Rev. 14, 348\u2013399 (1993).","journal-title":"Endocr. Rev."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.19","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2009.19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:46:55Z","timestamp":1710204415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2009.19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["BFnrendo200919"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2009.19","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}